\-\ Texto\\:\\ \ \(0\)\
\-\ rheumatoid\\ factor\\ positive\\ titer\\ 1\\:40\ \(0\)\
\-\ esr\\ 25\ \(1\)\
\-\ c\\-reactive\\ protein\\ 75\ \(0\)\
\-\ ana\\ negative\ \(0\)\
\-\ hla\\ b27\\ negative\ \(0\)\
\-\ rpr\\ non\\ reactive\ \(0\)\
\-\ treated\\ with\\ enbrel\\ for\\ arthritis\\.\ \(0\)\
\-\ there\\ are\\ multiple\\ small\\ ovoid\\ soft\\ tissue\\ densities\\ scattered\\ throughout\\ the\\ lungs\\ diffusely\\ and\\ bilaterally\\.\ \(0\)\
\-\ rheumatoid\\ arthritis\\ and\\ rheumatoid\\ lund\\ nodules\ \(0\)\
\-\ rheumatoid\\ nodules\ \(0\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 52\\ yo\\ man\\ with\\ rheumatoid\\ arthritis\\,\\ but\\ without\\ pulmonary\\ complaints\\ presents\\ for\\ \\"screening\\"\\ chest\\ x\\-ray\\ prior\\ to\\ starting\\ immune\\ modulation\\ therapy\\ \\(enbrel\\)\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rheumatoid\\:\\ 0\\.25227468317843554\ \(0\)\
\-\ enbrel\\:\\ 0\\.20305928108516383\ \(0\)\
\-\ arthritis\\:\\ 0\\.1369024668766119\ \(0\)\
\-\ b27\\:\\ 0\\.11019398029958123\ \(0\)\
\-\ modulation\\:\\ 0\\.11019398029958123\ \(0\)\
\-\ 1\\:40\\:\\ 0\\.10152964054258191\ \(0\)\
\-\ lund\\:\\ 0\\.10152964054258191\ \(0\)\
\-\ hla\\:\\ 0\\.09646132669122987\ \(0\)\
\-\ nodules\\:\\ 0\\.0885629716350688\ \(0\)\
\-\ titer\\:\\ 0\\.08272867308287848\ \(0\)\
\-\ c\\-reactive\\:\\ 0\\.07913264717723123\ \(0\)\
\-\ rpr\\:\\ 0\\.07913264717723123\ \(0\)\
\-\ ana\\:\\ 0\\.07274732688015634\ \(0\)\
\-\ immune\\:\\ 0\\.07100030260046686\ \(0\)\
\-\ starting\\:\\ 0\\.0681027824247503\ \(0\)\
\-\ negative\\:\\ 0\\.06380300403437186\ \(0\)\
\-\ densities\\:\\ 0\\.05922476225075973\ \(0\)\
\-\ ovoid\\:\\ 0\\.05880805699741484\ \(0\)\
\-\ 52\\:\\ 0\\.05691048183656479\ \(0\)\
\-\ protein\\:\\ 0\\.0548087703140398\ \(0\)\
\-\ 75\\:\\ 0\\.054660839593452276\ \(0\)\
\-\ factor\\:\\ 0\\.05451463909641238\ \(0\)\
\-\ esr\\:\\ 0\\.054086025677929486\ \(0\)\
\-\ diffusely\\:\\ 0\\.05394635942045292\ \(0\)\
\-\ granulomatous\\:\\ 0\\.05155213177171694\ \(0\)\
\-\ reactive\\:\\ 0\\.050560422493760415\ \(0\)\
\-\ scattered\\:\\ 0\\.04974045646268776\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.04815842242133239\ \(0\)\
\-\ complaints\\:\\ 0\\.046369661875823975\ \(0\)\
\-\ screening\\:\\ 0\\.04556293036160433\ \(0\)\
\-\ non\\:\\ 0\\.044153933690356376\ \(0\)\
\-\ 25\\:\\ 0\\.043177828228213415\ \(0\)\
\-\ lungs\\:\\ 0\\.04044735747475345\ \(0\)\
\-\ throughout\\:\\ 0\\.03998434157874908\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03508381548154879\ \(0\)\
\-\ disease\\:\\ 0\\.03491843853039261\ \(0\)\
\-\ positive\\:\\ 0\\.03466106987855146\ \(0\)\
\-\ yo\\:\\ 0\\.03214189404128453\ \(0\)\
\-\ treated\\:\\ 0\\.03197313545104824\ \(0\)\
\-\ pulmonary\\:\\ 0\\.031206878877750796\ \(0\)\
\-\ therapy\\:\\ 0\\.028558009953007665\ \(0\)\
\-\ prior\\:\\ 0\\.027426409652529543\ \(0\)\
\-\ metastatic\\:\\ 0\\.02688886754520113\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.026251687970397716\ \(0\)\
\-\ soft\\:\\ 0\\.026011584549919378\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.02574686877477804\ \(0\)\
\-\ chest\\:\\ 0\\.025559112500718986\ \(0\)\
\-\ tissue\\:\\ 0\\.025317764855657423\ \(0\)\
\-\ man\\:\\ 0\\.02526164803862499\ \(0\)\
\-\ without\\:\\ 0\\.025150164579477004\ \(0\)\
\-\ small\\:\\ 0\\.024607191054763985\ \(0\)\
\-\ but\\:\\ 0\\.022781291262919223\ \(0\)\
\-\ multiple\\:\\ 0\\.022497575043490863\ \(0\)\
\-\ presents\\:\\ 0\\.021820553693849075\ \(0\)\
\-\ for\\:\\ 0\\.01822770371606788\ \(0\)\
\-\ there\\:\\ 0\\.01589644445581236\ \(0\)\
\-\ are\\:\\ 0\\.014560923406620022\ \(0\)\
\-\ \\(\\:\\ 0\\.009029521578048257\ \(0\)\
\-\ \\)\\:\\ 0\\.008919221151416313\ \(0\)\
\-\ to\\:\\ 0\\.005338351355537329\ \(0\)\
\-\ and\\:\\ 0\\.004500225143305461\ \(0\)\
\-\ \\,\\:\\ 0\\.0033838758189660926\ \(0\)\
\-\ with\\:\\ 0\\.0029251044022472437\ \(0\)\
\-\ the\\:\\ 0\\.0017281160587953226\ \(0\)\
\-\ \\.\\:\\ 0\\.0013312326036504852\ \(0\)\
